Results 121 to 130 of about 14,735 (228)

Pharmacokinetic Drug Interaction Studies with Enzalutamide [PDF]

, 2015
Jacqueline A. Gibbons, Jan Noukens, Jan-Stefan van der Walt, Joyce Mordenti, Michiel de Vries, Roelof Mol, Taoufik Ouatas, Walter Krauwinkel, Yoshiaki Ohtsu   +8 more
core   +1 more source

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer [PDF]

, 2010
Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen, Mansoor Raza Mirza, Rasmus S. Pedersen, Flemming Nielsen, Kristin Skougaard, Jessica Wihl, Nina Keldsen, Per Damkier, Lena E. Friberg, C. Peterson, Werner Vach, Mats O. Karlsson, Kim Brøsen   +14 more
openalex   +1 more source

Time-dependent Inhibition of CYP2C8 and CYP2C19 by Hedera helix Extracts, A Traditional Respiratory Herbal Medicine [PDF]

, 2017
Shaheed Ur Rehman, In Ho Kim, Min Ji Choi, Seung Up Kim, Yonghui Zhang, Hye Jin Yoo   +5 more
openalex   +1 more source

CYP2C8*7 Allele [PDF]

, 2020
openaire   +1 more source

The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)‐ibuprofen enantiomer in healthy subjects [PDF]

, 2004
Carmen Martínez, Elena Garcı́a-Martı́n, Gerardo Blanco‐Fernández, Francisco J. G. Gamito, José M. Ladero, José A. G. Agúndez   +5 more
openalex   +1 more source

Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypes. [PDF]

Drug Metab Dispos
Latham BD, Montazeri P, Lanphier RM, Gerringer AJ, Interrante T, Jones CD, De Busysscher T, Fallon JK, Jackson KD.   +8 more
europepmc   +1 more source

A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6

Veronica Di Paolo, Francesco Maria Ferrari, Davide Veronese, Italo Poggesi, Luigi Quintieri   +4 more
openalex   +1 more source

The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects [PDF]

, 2004
Mikko Niemi, Lauri Kajosaari, Mikko Neuvonen, Janne T. Backman, Pertti J. Neuvonen   +4 more
openalex   +1 more source

Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases. [PDF]

Arch Pharm Res
Lee H, Kwon YJ, Chun YJ.
europepmc   +1 more source

Physiologically based pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction

Nilesh Gaud, Dawid Gogola, Anna Kowal-Chwast, Ewelina Gabor-Worwa, Peter Littlewood, Krzysztof Brzózka, Kamil Kuś, Maria Walczak   +7 more
openalex   +2 more sources